Rogiers, A <br/><br/>
Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  Jul 2020 
 - 3267-3278 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-019-05168-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Anxiety--etiology<br/>Cancer Survivors--psychology<br/>Depression--etiology<br/>Female<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neurocognitive Disorders--etiology<br/>Patient Reported Outcome Measures<br/>Pilot Projects<br/>Prospective Studies<br/>Quality of Life<br/>Stress, Psychological--etiology